NCT01058824View on ClinicalTrials.gov

Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Bacterial Infections
Interventions
DRUG

Lincomycin

Single Dose Hard Gelatin Capsule - oral - 500 mg

DRUG

Lincomycin

Single Dose Hard Gelatin Capsule - oral - 500 mg

Trial Locations (2)

13012-000

Pfizer Investigational Site, Campinas

13012-431

Pfizer Investigational Site, Campinas

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY